Entering text into the input field will update the search result below

Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on Q1 2022 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2022 Results Conference Call May 3, 2022 8:00 AM ET

Company Participants

Ran Meir - Head, IR

Kåre Schultz - CEO

Eli Kalif - CFO

Sven Dethlefs - Head, North America Commercial

Conference Call Participants

Balaji Prasad - Barclays

David Amsellem - Piper Sandler

Eric Masane - Evercore ISI

Chris Schott - JPMorgan

Elliot Wilbur - Raymond James

Ronny Gal - Bernstein

Gary Nachman - BMO Capital Markets

Bhavin Patel - Bank of America


Good day, and thank you for standing by, and welcome to Teva's First Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being record it. [Operator Instructions]

I would now like to hand the conference over to your first speaker today, Ran Meir, Senior Vice President, Investor Relations. Please go ahead, sir.

Ran Meir

Thank you, Annette. Thank you, everyone, for joining us today to discuss Teva's first quarter 2022 financial results. We hope you have had an opportunity to review our earnings press release which was issued earlier this morning. A copy of this press release as well as a copy of the slides being presented on this call can be found on our website at tevapharm.com.

Please review our forward-looking statements on Slide number 2. Additional information regarding these statements and our non-GAAP financial measures is available on our earnings release and in our SEC Forms, 10-K and 10-Q.

To begin today's call, Kåre Schultz, Teva's CEO, will provide an overview of the first quarter performance, recent events and priorities going forward. Our CFO, Eli Kalif, will follow up by reviewing the financial results in more detail, including our 2022 financial outlook.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.